References
- Tsiara S, Elisaf M, Mikhailidis DP. Influence of smoking on predictors of vascular disease. Angiology 2003;54:507–30.
- Pittilo RM. Cigarette smoking, endothelial injury and cardiovascular disease. Int J Exp Path 2000;81:219–30.
- Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature1993;362:801–9.
- Blaes N, Piovella F, Samaden A, Boutherin-Falson O, Ricetti M. Nicotine alters fibronectin and factor VIII/vWF in human vascular endothelial cells. Br J Haematol 1986;64:675–87.
- Kalra J, Chaudhary AK, Prasad K. Increased production of oxygen free radicals in cigarette smokers. Int J Exp Pathol 1991;72:1–7.
- Kumari M, Marmot M, Brunner E. Social determinants of von Willebrand factor – The Whitehall II Study. Arterioscler Thromb Vasc Biol 2000;20:1842–7.
- Blann AD, McCollum CN. von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg 1994;8:10–15.
- Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997;34:255–65.
- Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991;66:351–5.
- Thompson SG, Kienast J, Pyke SD, Haverkate F, van del Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European concerted action on thrombosis and disabilities angina pectoris study group. N Engl J Med 1995;332: 635–41.
- Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikama K. Structure of von Willebrand factor-cleaving protease (ADAMTS-13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001;276:1059–63.
- Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996;87:4223–34.
- Levy GA, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemienika DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001;413:488–94.
- Remuzzi G. Is ADAMTA-13 deficiency specific for thrombotic thrombocytopenic purpura? No. J Thromb Haemost 2003;1:632–4.
- Mannucci PM, Capoferri C, Canciani MT. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease. Br J Haematol 2004;126:213–8.
- Blann AD, Kirkpatrick U, Devine C, Naser S, McCollum CN. The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis 1998;141:133–9.
- Prisco D, Fedi T, Brunelli L, Chiarugi L, Lombardi A, Gianni R., Santoro E, Cappelletti C, Pepe G, Gensini GF, Abbate R. The influence of smoking on von Willebrand factor is already manifesting in healthy adolescent females: the Floren-teen (Florence Teenager) study. Int J Clin Lab Res 1999;29:150–4.
- Rastogi R, Shrivastava SS, Mehrota TN, Singh VS, Gupta MK. Lipid profile in smokers. J Assoc Physicians India 1989;37:764–6.
- Casey RG, Joyce M, Roche-Nagle G, Cox D, Bouchier-Hayes DJ. Young male smokers have altered platelets and endothelium that precedes atherosclerosis. J Surg Res 2004;116:227–33.
- Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005;26:1765–73.
- Gader A, Bahakim H, Awadallah S, Malaika S. Ethnic variations in the haemostatic system: comparison between Arabs, Westerners (Europeans and Americans), Asians and Africans. Blood Coagul Fibrinolysis 1995;6:537–42.
- Sukhu K, Poovalingam V, Mahomed R, Giangrande PL. Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease. Clin Lab Haematol 2003;25:247–9.
- Favaloro EJ, Facey D, Grispo L. Laboratory assays for von Willebrand factor: use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms. Am J Clin Pathol 1995;104:264–71.
- Favaloro EJ, Koutts J. Laboratory assays for von Willebrand factor: relative contribution to the diagnosis of von Willebrand's disease. Pathology 1997;29:385–91.
- Al-Awadhi AM, Jadaon MM, Al-Jafar HA, Al-Wazzan HJ. ADAMTS-13 antigen and activity levels in thrombocytopenic disorders including thrombotic thrombocytopenic purpura in Kuwait. Acta Haematologica 2011;125: 160–6.